IAAF will ignore court on important issue in Semenya case


Track and field’s governing body said Thursday it plans to enforce its new rules on testosterone levels in female runners more widely than sports’ highest court is recommending, dealing another setback to Olympic sensation Caster Semenya.

On Wednesday, the Court of Arbitration for Sport ruled that the IAAF can force women like Semenya with unusually high testosterone to take medication to lower their levels of the muscle-building male sex hormone if they want to compete in events from 400 meters to the mile.

But the court also recommended the IAAF not enforce the rules in the 1,500 meters and the mile, saying there is not enough evidence that high testosterone gives such women a competitive edge at those distances.

Asked on Thursday whether he would heed the court’s advice, IAAF president Sebastian Coe gave a one-word answer: “No.” In a follow-up statement, the IAAF said it has enough evidence to apply the rules at the longer distances.

That decision closes off one way Semenya could have continued to compete without having to take hormone-lowering drugs.

Mandatory Evacuations Announced for Parts of US City, Residents Warned to Prepare for Overnight Shelter Stays

The 28-year-old South African is a two-time Olympic gold medalist in the 800 meters and a three-time world champion. But she has also run the 1,500 meters and has had some success, winning the bronze at the 2017 world championships.

She could still run even longer distances, like the 5,000 meters, without having to take medication. But she hasn’t indicated what she will do.

Semenya has run the fourth, sixth and eighth fastest times ever in the two-lap 800-meter race. But her rivals have complained about having to compete against someone with hyperandrogenism, or unusually high levels of naturally occurring testosterone, a hormone that contributes to muscle tone and bone mass.

In Wednesday’s ruling, the court said the IAAF’s testosterone regulations are “necessary, reasonable and proportionate means” of “preserving the integrity of female athletics.”

Semenya is expected to run on Friday in Doha, Qatar, for the last time before the IAAF rules start being enforced next week. She has accused the governing body of singling her out, saying after the ruling: “For a decade the IAAF has tried to slow me down, but this has actually made me stronger.”

Indian sprinter Dutee Chand has also been publicly identified as having high testosterone. Olympic silver medalist and Semenya rival Francine Niyonsaba of Burundi has confirmed she, too, has hyperandrogenism. She will also compete in Doha.


More AP sports: and

The Western Journal has not reviewed this Associated Press story prior to publication. Therefore, it may contain editorial bias or may in some other way not meet our normal editorial standards. It is provided to our readers as a service from The Western Journal.

Truth and Accuracy

Submit a Correction →

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands. Photo credit: @AP on Twitter
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
New York City